Hydrochlorothiazide for Ménière's Disease
Hydrochlorothiazide (or other thiazide diuretics) is a reasonable fourth-line treatment option for this patient with Ménière's disease, following dietary sodium restriction, betahistine, and intratympanic corticosteroids. This represents a conservative medical approach before considering more aggressive interventions like intratympanic gentamicin or surgical options.
Rationale for Diuretic Therapy
The 2020 AAO-HNS Clinical Practice Guideline for Ménière's Disease 1, 2 lists diuretics as part of the medical management hierarchy for MD. The guideline specifically mentions:
- Diuretics—medications that remove excess body fluid 1
- These are positioned after dietary modifications but before more invasive interventions
The theoretical mechanism relates to MD's association with endolymphatic hydrops (inner ear fluid volume increases). Diuretics aim to reduce this fluid accumulation, though the evidence base is not as robust as for some other interventions 1.
Treatment Algorithm Position
Based on the guideline's treatment hierarchy 1, hydrochlorothiazide fits as follows:
- First-line: Low-sodium diet (1500-2300 mg daily)
- Second-line: Betahistine (histamine analogue)
- Third-line: Intratympanic steroids
- Fourth-line: Thiazide diuretics (hydrochlorothiazide)
- Fifth-line: Intratympanic gentamicin
- Sixth-line: Surgical options (endolymphatic sac decompression, vestibular nerve section, labyrinthectomy)
Clinical Considerations
Important caveats about diuretic therapy:
- The evidence for diuretics in MD is not particularly strong, and up to 60% of patients show improvement with placebo in published RCTs 1
- This makes it difficult to definitively attribute symptom improvement to the medication itself
- However, given the relatively benign side effect profile compared to ablative therapies, it remains a reasonable conservative option
Monitoring requirements:
- Electrolytes (potassium, sodium) should be monitored periodically
- Blood pressure monitoring
- Assess for orthostatic symptoms
- Evaluate vertigo frequency and severity at follow-up visits
When to Escalate Beyond Diuretics
If hydrochlorothiazide fails to provide adequate vertigo control after an appropriate trial (typically 2-3 months), the next step would be intratympanic gentamicin for chemical ablation of vestibular function 3. This is reserved for patients with:
- Persistent disabling vertigo despite maximal medical therapy
- Preserved hearing that you wish to maintain (as opposed to labyrinthectomy)
- Willingness to accept permanent vestibular weakness requiring rehabilitation
The key principle is stepwise escalation from least to most invasive, always weighing the goal of vertigo control against the risks of hearing loss and permanent vestibular dysfunction 1, 3.